Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Endrenyi

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Cardiovascular Journal of Africa|June 10, 2010
Bioequivalence: tried and testedR Schall, L Endrenyi
Pharmaceutical Research|April 1, 1999
Subject-by-formulation interaction in determinations of individual bioequivalence: bias and prevalenceL Endrenyi, L Tothfalusi
Journal of Pharmaceutical Sciences|March 1, 1997
Secondary metrics for the assessment of bioequivalenceL Endrenyi, L Tothfalusi
Clinical Pharmacology and Therapeutics|September 1, 1994
Comparative efficiencies of randomized concentration- and dose-controlled clinical trialsL Endrenyi, J Zha
Journal of Pharmaceutical Sciences|May 20, 1998
Model-independent estimation of lag times with first-order absorption and dispositionF Csizmadia, L Endrenyi
Pharmaceutical Research|June 1, 1995
Without extrapolation, Cmax/AUC is an effective metric in investigations of bioequivalenceL Tothfalusi, L Endrenyi
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1993
Variation of Cmax and Cmax/AUC in investigations of bioequivalenceL Endrenyi, W Yan
Trends in Pharmacological Sciences|August 1, 1991
Evaluation of two assumptions: single straight line, and single normal distributionL Endrenyi, M Patel
British Journal of Clinical Pharmacology|August 1, 1991
A new, sensitive graphical method for detecting deviations from the normal distribution of drug responses: the NTV plotL Endrenyi, M Patel
Journal of Theoretical Biology|December 21, 1986
Design of experiments for the precise estimation of dose-response parameters: the Hill equationM Bezeau, L Endrenyi
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Cardiovascular Journal of Africa|June 10, 2010
Bioequivalence: tried and testedR Schall, L Endrenyi
Pharmaceutical Research|April 1, 1999
Subject-by-formulation interaction in determinations of individual bioequivalence: bias and prevalenceL Endrenyi, L Tothfalusi
Journal of Pharmaceutical Sciences|March 1, 1997
Secondary metrics for the assessment of bioequivalenceL Endrenyi, L Tothfalusi
Clinical Pharmacology and Therapeutics|September 1, 1994
Comparative efficiencies of randomized concentration- and dose-controlled clinical trialsL Endrenyi, J Zha
Journal of Pharmaceutical Sciences|May 20, 1998
Model-independent estimation of lag times with first-order absorption and dispositionF Csizmadia, L Endrenyi
Pharmaceutical Research|June 1, 1995
Without extrapolation, Cmax/AUC is an effective metric in investigations of bioequivalenceL Tothfalusi, L Endrenyi
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1993
Variation of Cmax and Cmax/AUC in investigations of bioequivalenceL Endrenyi, W Yan
Trends in Pharmacological Sciences|August 1, 1991
Evaluation of two assumptions: single straight line, and single normal distributionL Endrenyi, M Patel
British Journal of Clinical Pharmacology|August 1, 1991
A new, sensitive graphical method for detecting deviations from the normal distribution of drug responses: the NTV plotL Endrenyi, M Patel
Journal of Theoretical Biology|December 21, 1986
Design of experiments for the precise estimation of dose-response parameters: the Hill equationM Bezeau, L Endrenyi
Pageof 9